C4 Therapeutics, Inc. (NASDAQ:CCCC) Shares Sold by D. E. Shaw & Co. Inc.
D. E. Shaw & Co. Inc. lessened its position in C4 Therapeutics, Inc. (NASDAQ:CCCC – Free Report) by 35.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 76,479 shares of the company’s stock after selling 42,413 shares during the […]
D. E. Shaw & Co. Inc. lessened its position in C4 Therapeutics, Inc. (NASDAQ:CCCC – Free Report) by 35.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 76,479 shares of the company’s stock after selling 42,413 shares during the […]
